Back
Extension of the therapeutic spectrum in castration-resistant prostate cancer: Osteoclast inhibition with denosumab.
Journal article

Extension of the therapeutic spectrum in castration-resistant prostate cancer: Osteoclast inhibition with denosumab.

  • Wolff JM 1 AKH Viersen, Viersen, Germany ; 2 Kantonsspital St. Gallen, St. Gallen, Switzerland.
  • Schmid HP 1 AKH Viersen, Viersen, Germany ; 2 Kantonsspital St. Gallen, St. Gallen, Switzerland.
  • 2016-01-28
Published in:
  • Translational andrology and urology. - 2012
Language
  • English
Identifiers
Persistent URL
https://sonar.ch/global/documents/186556
Statistics
Document views: 24 File downloads: